The Bulletin
The Times


.

Kazia Executes Agreement To Commence GBM Agile Pivotal Study-PR Newswire APAC

  • Written by PR Newswire
Kazia Executes Agreement To Commence GBM Agile Pivotal Study-PR Newswire APAC

SYDNEY, Oct. 16, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a definitive agreement with the Global Coalition for Adaptive Research (GCAR) to commence Kazia's participation in the GBM AGILE pivotal study in...

hacklink esim balkanzlibraryzlibrarySahabetuk casinos not on gamstopGamStopgrandpashabet girişviagra 100 mg fiyattaraftarium24taraftarium24extrabet